Page 5 - Linzess Constella News Today : Breaking News, Live Updates & Top Stories | Vimarsana

- Reports Full-Year Diluted EPS of $2.72 on a GAAP Basis; Adjusted Diluted EPS of $10.56
- Delivers Full-Year Net Revenues of $45.804 Billion on a GAAP Basis, an Increase of 37.7 Percent on a Reported Basis; Adjusted Net Revenues Were $45.784 Billion
- Full-Year Global Net Revenues from the Immunology Portfolio Were $22.153 Billion, an Increase of 13.2 Percent on a Reported Basis, or 13.4 Percent on an Operational Basis; U.S. Humira Net Revenues Were $16.112 Billion, an Increase of 8.4 Percent; Internationally, Humira Net Revenues Were $3.720 Billion, a Decrease of 13.6 Percent on a Reported Basis, or 12.5 Percent on an Operational Basis, Due to Biosimilar Competition; Global Skyrizi Net Revenues Were $1.590 Billion; Global Rinvoq Net Revenues Were $731 Million ....

United States , Alphagan Combigan , Linzess Constella , Richarda Gonzalez , Lumigan Ganfort , Orilissa Oriahnn , Janssen Biotech Inc , American Society Of Hematology Annual Meeting , Boehringer Ingelheim , European Union , Other Women Health , Abbvie Inc , National Urban League , Drug Administration , Women Health , United Negro College Fund , European Commission , Health Assessment Questionnaire Disability Index , American Academy Of Ophthalmology , Exchange Commission , Mel School , Roche Group , University Of Chicago Medicine Urban Health Initiative , Botox Cosmetic , Botox Therapeutic , Key Product Revenues ,